TruSpine is a medical device company in the spinal device market.
The company is developing disruptive technologies for use in the spinal stabilisation market, commencing with the following three devices:
Cervi-LOK – for the cervical and upper thoracic spine
Faci-LOK – for the lumbar and lower thoracic spine, and
GRASP Laminoplasty – a treatment for decompression of the spinal cord.
They announced yesterday their admission to trading on AQSE. The admission will enable Truspine to grow as they move towards achieving the necessary approvals for their unique suite of spinal (vertebral) stabilisation products.
Leading audit, accountancy, tax and advisory firm PKF acted as reporting accountant on the transaction and the capital markets team included Joseph Archer, Adam Humphreys and Lauren Haslam.
“The PKF capital markets team were an integral part of our listing process. Their expertise and proactive support enabled us to meet our deadlines for a successful listing.” Norman Lott, Finance Director | Truspine Technologies PLC
Find out more on how our capital markets team can support you and your business here.